Literature DB >> 28024992

Spironolactone.

Laura Carone1, Stephen G Oxberry2, Robert Twycross3, Sarah Charlesworth4, Mary Mihalyo5, Andrew Wilcock6.   

Abstract

Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28024992     DOI： 10.1016/j.jpainsymman.2016.12.320

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


  6 in total

1.  Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis-An In Vitro Study.

Authors:  Eszter Fidrus; Csaba Hegedűs; Eszter Anna Janka; György Paragh; Gabriella Emri; Éva Remenyik
Journal:  Int J Mol Sci       Date:  2021-02-06       Impact factor: 5.923

Review 2.  Sulfated and Sulfur-Containing Steroids and Their Pharmacological Profile.

Authors:  Tatyana A Pounina; Tatyana A Gloriozova; Nick Savidov; Valery M Dembitsky
Journal:  Mar Drugs       Date:  2021-04-24       Impact factor: 5.118

Review 3.  The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review.

Authors:  Farnoosh Nozari; Nasrin Hamidizadeh
Journal:  Int J Hypertens       Date:  2022-01-21       Impact factor: 2.420

4.  Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation.

Authors:  Manasa Tatipalli; Vijay Kumar Siripuram; Tao Long; Diana Shuster; Galina Bernstein; Pierre Martineau; Kim A Cook; Rodrigo Cristofoletti; Stephan Schmidt; Valvanera Vozmediano
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

5.  Spironolactone Ameliorates Senescence and Calcification by Modulating Autophagy in Rat Tendon-Derived Stem Cells via the NF-κB/MAPK Pathway.

Authors:  Kai Xu; Changjian Lin; Diana Ma; Mengyao Chen; Xing Zhou; Yuzhe He; Safwat Adel Abdo Moqbel; Chiyuan Ma; Lidong Wu
Journal:  Oxid Med Cell Longev       Date:  2021-06-30       Impact factor: 6.543

6.  Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca2+/Calcineurin/p-NFATc3 Pathway.

Authors:  Xin Wang; Wenting Zhang; Jingtao Na; Yanping Huo; Yacheng Wang; Ketong Liu
Journal:  J Healthc Eng       Date:  2021-12-16       Impact factor: 2.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.